Manchester Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
308
+250
+431% +$66.3K 0.02% 324
2026
Q1
$6.36K Buy
58
+49
+544% +$6.98K ﹤0.01% 857
2025
Q4
$1.5K Sell
9
-376
-98% -$62.9K ﹤0.01% 1073
2025
Q3
$75.4K Sell
385
-98
-20% -$16.1K 0.01% 477
2025
Q2
$43.7K Buy
483
+283
+142% +$22.4K 0.01% 585
2025
Q1
$11.9K Buy
+200
New +$18.5K ﹤0.01% 791

Other funds holding ALAB

Manchester Capital Management's ALAB Position: Q2 2026 in Review

Manchester Capital Management increased its Astera Labs (ALAB) stake by 431% in Q2 2026, buying an estimated $66.3K and bringing the position to 308 shares worth $149K. The position accounts for 0.02% of the portfolio, ranked #324.

Manchester Capital Management first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Manchester Capital Management held 308 shares of Astera Labs worth $149K as of Q2 2026.
  • Manchester Capital Management bought 250 Astera Labs shares in Q2 2026, an estimated $66.3K.
  • Astera Labs made up 0.02% of Manchester Capital Management's portfolio in Q2 2026, its #324 holding.
  • Manchester Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.